Search

Your search keyword '"Mouron, Silvana"' showing total 8 results
Start Over Author "Mouron, Silvana" Publisher american association for cancer research (aacr)
8 results on '"Mouron, Silvana"'

1. Figure S2 from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Author

Quintela-Fandino, Miguel, primary, Morales, Serafín, primary, Cortés-Salgado, Alfonso, primary, Manso, Luis, primary, Apala, Juan V., primary, Muñoz, Manuel, primary, Gasol Cudos, Ariadna, primary, Salla Fortuny, Joel, primary, Gion, María, primary, Lopez-Alonso, Antonio, primary, Cortés, Javier, primary, Guerra, Juan, primary, Malón, Diego, primary, Caleiras, Eduardo, primary, Mulero, Francisca, primary, and Mouron, Silvana, primary

Published
2023
Full Text
View/download PDF

2. Figure S2 from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Author

Quintela-Fandino, Miguel, primary, Morales, Serafín, primary, Cortés-Salgado, Alfonso, primary, Manso, Luis, primary, Apala, Juan V., primary, Muñoz, Manuel, primary, Gasol Cudos, Ariadna, primary, Salla Fortuny, Joel, primary, Gion, María, primary, Lopez-Alonso, Antonio, primary, Cortés, Javier, primary, Guerra, Juan, primary, Malón, Diego, primary, Caleiras, Eduardo, primary, Mulero, Francisca, primary, and Mouron, Silvana, primary

Published
2023
Full Text
View/download PDF

3. Figure S1 from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Author

Quintela-Fandino, Miguel, primary, Morales, Serafín, primary, Cortés-Salgado, Alfonso, primary, Manso, Luis, primary, Apala, Juan V., primary, Muñoz, Manuel, primary, Gasol Cudos, Ariadna, primary, Salla Fortuny, Joel, primary, Gion, María, primary, Lopez-Alonso, Antonio, primary, Cortés, Javier, primary, Guerra, Juan, primary, Malón, Diego, primary, Caleiras, Eduardo, primary, Mulero, Francisca, primary, and Mouron, Silvana, primary

Published
2023
Full Text
View/download PDF

4. Figure S1 from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Author

Quintela-Fandino, Miguel, primary, Morales, Serafín, primary, Cortés-Salgado, Alfonso, primary, Manso, Luis, primary, Apala, Juan V., primary, Muñoz, Manuel, primary, Gasol Cudos, Ariadna, primary, Salla Fortuny, Joel, primary, Gion, María, primary, Lopez-Alonso, Antonio, primary, Cortés, Javier, primary, Guerra, Juan, primary, Malón, Diego, primary, Caleiras, Eduardo, primary, Mulero, Francisca, primary, and Mouron, Silvana, primary

Published
2023
Full Text
View/download PDF

5. Abstract P5-02-28: p27Kip1 V109G single-nucleotide polymorphism (SNP): pinpointing the hormone-receptor positive breast cancer subpopulation that requires CDK4/6 inhibitors in addition to endocrine therapy

Author

Quintela-Fandino, Miguel, primary, Mouron, Silvana, additional, Bueno, Maria J., additional, Muñoz, Manuel, additional, Torres, Raul, additional, Rodriguez, Sandra, additional, Sánchez-Bayona, Rodrigo, additional, Manso, Luis, additional, Silva, Jorge, additional, and Malumbres, Marcos, additional

Published
2023
Full Text
View/download PDF

6. Abstract OT2-19-08: Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6

Author

Manso, Luis, primary, Cortes, Alfonso, additional, Cejalvo, Juan M, additional, Morales, Serafin, additional, Saenz, Jose A García, additional, Colomer, Ramon, additional, Sanchez-Bayona, Rodrigo, additional, Silva, Jorge, additional, Guerra, Juan A, additional, Malon, Diego, additional, Mouron, Silvana, additional, Caleiras, Eduardo, additional, and Quintela-Fandino, Miguel, additional

Published
2022
Full Text
View/download PDF

7. Abstract OT2-20-01: Rogaratinib, palbociclib and fulvestrant in advanced hormone receptor-positive (HR+), FGFR1/2-positive breast cancer: Phase I trial plus an expansion cohort

Author

Pernas, Sonia, primary, Hernando, Cristina, additional, Bermejo, Begoña, additional, Martinez-Jañez, Noelia, additional, Saenz, Jose A García, additional, Morales, Serafin, additional, Manso, Luis, additional, Silva, Jorge, additional, Guerra, Juan A, additional, Malon, Diego, additional, Mouron, Silvana, additional, Caleiras, Eduardo, additional, and Quintela-Fandino, Miguel, additional

Published
2022
Full Text
View/download PDF

8. Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

Author

Quintela-Fandino, Miguel, primary, Morales, Serafín, additional, Cortés-Salgado, Alfonso, additional, Manso, Luis, additional, Apala, Juan V., additional, Muñoz, Manuel, additional, Gasol Cudos, Ariadna, additional, Salla Fortuny, Joel, additional, Gion, María, additional, Lopez-Alonso, Antonio, additional, Cortés, Javier, additional, Guerra, Juan, additional, Malón, Diego, additional, Caleiras, Eduardo, additional, Mulero, Francisca, additional, and Mouron, Silvana, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results